Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-sensitive drugs, these kinds of programs such as a syringe with the oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite low permeability to oxygen and comprise